Pamidronate Injection

Generic name: Pronounced as (pa mi droe' nate)
Brand names
  • Aredia®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 12/15/2015

Pamidronate is used to treat high levels of calcium in the blood that may be caused by certain types of cancer. Pamidronate is also used along with cancer chemotherapy to treat bone damage caused by multiple myeloma (cancer that begins in the plasma cells [a type of white blood cell that produces substances needed to fight infection]) or by breast cancer that has spread to the bones. Pamidronate is also used to treat Paget's disease (a condition in which the bones are soft and weak and may be deformed, painful, or easily broken). Pamidronate injection is in a class of medications called bisphosphonates. It works by slowing bone breakdown, increasing bone density (thickness) and decreasing the amount of calcium released from the bones into the blood.

Pamidronate injection comes as a solution (liquid) to inject into a vein slowly, over 2 to 24 hours. It is usually injected by a health care provider in a doctor's office, hospital, or clinic. It may be given once every 3 to 4 weeks, once a day for 3 days in a row, or as a single dose that may be repeated after 1 week or longer. The treatment schedule depends on your condition.

Your doctor may recommend a calcium supplement and a multivitamin containing vitamin D to take during your treatment. You should take these supplements every day as directed by your doctor.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before receiving pamidronate injection,

  • tell your doctor and pharmacist if you are allergic to pamidronate injection, alendronate (Fosamax), etidronate (Didronel), risedronate (Actonel), tiludronate (Skelid), zoledronic acid (Zometa), any other medications, or any of the ingredients in pamidronate injection. Ask your pharmacist for a list of the ingredients.

  • tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: cancer chemotherapy medications; oral steroids such as dexamethasone (Decadron, Dexone), methylprednisolone (Medrol), and prednisone (Deltasone);and thalidomide (Thalomid). Your doctor may need to change the doses of your medications or monitor you carefully for side effects. Many other medications may also interact with pamidronate injection, so be sure to tell your doctor about all the medications you are taking, even those that do not appear on this list.

  • tell your doctor if you are being treated with radiation therapy and if you have or have ever had thyroid surgery, seizures, or liver or kidney disease.

  • tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. You should use a reliable method of birth control to prevent pregnancy while you are receiving pamidronate. If you become pregnant while receiving pamidronate, call your doctor immediately. Talk to your doctor if you plan to become pregnant at any time in the future because pamidronate may remain in your body for years after you stop using it.

  • you should know that pamidronate may cause serious problems with your jaw, especially if you have dental surgery or treatment while you are taking the medication. A dentist should examine your teeth and perform any needed treatments before you start to receive pamidronate. Be sure to brush your teeth and clean your mouth properly while you are receiving pamidronate. Talk to your doctor before having any dental treatments while you are receiving this medication.

  • you should know that pamidronate injection may cause severe bone, muscle, or joint pain. You may begin to feel this pain within days, months, or years after you first receive pamidronate injection. Although this type of pain may begin after you have received pamidronate injection for some time, it is important for you and your doctor to realize that it may be caused by pamidronate. Call your doctor right away if you experience severe pain at any time during your treatment with pamidronate inejction. Your doctor may stop giving you pamidronate injection and your pain may go away after you stop treatment with this medication.

Unless your doctor tells you otherwise, continue your normal diet

Call your doctor if you miss a dose of pamidronate or an appointment to receive a dose of pamidronate.

  • Pamidronate injection may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • redness, swelling, or pain in the injection spot

    • stomach pain

    • loss of appetite

    • constipation

    • nausea

    • vomiting

    • heartburn

    • change in ability to taste food

    • sores in the mouth

    • fever

    • headache

    • dizziness

    • excessive tiredness

    • difficulty falling asleep or staying asleep

    • coughing

    • difficulty urinating or painful urination

    • swelling of the hands, arms, feet, ankles, or lower legs

  • Some side effects can be serious. If you experience any of these symptoms, call your doctor immediately:

    • painful or swollen gums

    • loosening of the teeth

    • numbness or heavy feeling in the jaw

    • poor healing of the jaw

    • vomit that is bloody or looks like coffee grounds

    • bloody or black and tarry stools

    • shortness of breath

    • fast heartbeat

    • fainting

    • sudden tightening of muscles

    • numbness or tingling around the mouth

    • eye pain or tearing

  • Pamidronate injection may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

If you are administering this medication at home, your health care provider will tell you how to store it. Follow these instructions carefully.

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include:

  • fever

  • change in ability to taste food

  • sudden tightening of the muscles

  • numbness or tingling around the mouth

Keep all appointments with your doctor and the laboratory. Your doctor will order certain lab tests to check your body's response to pamidronate injection.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

  • ADP Sodium
  • AHPrBP Sodium

Drug Interaction
Montelukast Montelukast The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Montelukast.
Leflunomide Leflunomide The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Leflunomide.
Atorvastatin Atorvastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Atorvastatin.
Alendronate Alendronate The risk or severity of nephrotoxicity and hypocalcemia can be increased when Pamidronic acid is combined with Alendronic acid.
Calcium Carbonate Calcium Carbonate The serum concentration of Pamidronic acid can be decreased when it is combined with Calcium carbonate.
Cilostazol Cilostazol Pamidronic acid may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) Pamidronic acid may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Fenofibrate Fenofibrate Pamidronic acid may decrease the excretion rate of Fenofibrate which could result in a higher serum level.
Guanfacine Guanfacine Pamidronic acid may decrease the excretion rate of Guanfacine which could result in a higher serum level.
Magnesium Hydroxide Magnesium Hydroxide The serum concentration of Pamidronic acid can be decreased when it is combined with Magnesium hydroxide.
Magnesium Oxide Magnesium Oxide The serum concentration of Pamidronic acid can be decreased when it is combined with Magnesium oxide.
Mycophenolate Mycophenolate Pamidronic acid may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.
Nafarelin Nafarelin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Nafarelin.
Olsalazine Olsalazine The risk or severity of gastrointestinal bleeding can be increased when Olsalazine is combined with Pamidronic acid.
Potassium Potassium Pamidronic acid may decrease the excretion rate of Potassium cation which could result in a higher serum level.
Prednisone Prednisone Pamidronic acid may decrease the excretion rate of Prednisone which could result in a higher serum level.
Ranitidine Ranitidine Pamidronic acid may decrease the excretion rate of Ranitidine which could result in a higher serum level.
Reserpine Reserpine Pamidronic acid may decrease the excretion rate of Reserpine which could result in a higher serum level.
Rizatriptan Rizatriptan Pamidronic acid may decrease the excretion rate of Rizatriptan which could result in a higher serum level.
Sumatriptan Sumatriptan Pamidronic acid may decrease the excretion rate of Sumatriptan which could result in a higher serum level.
Tacrolimus Tacrolimus The risk or severity of nephrotoxicity and hypocalcemia can be increased when Tacrolimus is combined with Pamidronic acid.
Tiludronate Tiludronate The risk or severity of nephrotoxicity and hypocalcemia can be increased when Pamidronic acid is combined with Etidronic acid.
Triamcinolone Triamcinolone The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Triamcinolone.
Ampicillin Injection Ampicillin Injection Pamidronic acid may decrease the excretion rate of Ampicillin which could result in a higher serum level.
Doxycycline Injection Doxycycline Injection Pamidronic acid may decrease the excretion rate of Doxycycline which could result in a higher serum level.
Fluconazole Injection Fluconazole Injection Pamidronic acid may decrease the excretion rate of Fluconazole which could result in a higher serum level.
Foscarnet Injection Foscarnet Injection The risk or severity of nephrotoxicity can be increased when Pamidronic acid is combined with Foscarnet.
Hydromorphone Injection Hydromorphone Injection Pamidronic acid may decrease the excretion rate of Hydromorphone which could result in a higher serum level.
Levofloxacin Injection Levofloxacin Injection Pamidronic acid may decrease the excretion rate of Levofloxacin which could result in a higher serum level.
Meperidine Injection Meperidine Injection Pamidronic acid may decrease the excretion rate of Meperidine which could result in a higher serum level.
Metoclopramide Injection Metoclopramide Injection Pamidronic acid may decrease the excretion rate of Metoclopramide which could result in a higher serum level.
Vancomycin Injection Vancomycin Injection Pamidronic acid may decrease the excretion rate of Vancomycin which could result in a higher serum level.
Zidovudine Injection Zidovudine Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Zidovudine.
Altretamine Altretamine Pamidronic acid may decrease the excretion rate of Amphetamine which could result in a higher serum level.
Cefuroxime Cefuroxime The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefuroxime is combined with Pamidronic acid.
Cyclosporine Cyclosporine The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cyclosporine is combined with Pamidronic acid.
Torsemide Torsemide The risk or severity of hypocalcemia can be increased when Torasemide is combined with Pamidronic acid.
Eprosartan Eprosartan The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Eprosartan.
Meloxicam Meloxicam The risk or severity of gastrointestinal bleeding can be increased when Meloxicam is combined with Pamidronic acid.
Pantoprazole Pantoprazole Pamidronic acid may decrease the excretion rate of Pantoprazole which could result in a higher serum level.
Risedronate Risedronate The risk or severity of nephrotoxicity and hypocalcemia can be increased when Pamidronic acid is combined with Risedronic acid.
Temozolomide Temozolomide Pamidronic acid may decrease the excretion rate of Temozolomide which could result in a higher serum level.
Zaleplon Zaleplon Pamidronic acid may decrease the excretion rate of Zaleplon which could result in a higher serum level.
Perindopril Perindopril Pamidronic acid may decrease the excretion rate of Perindopril which could result in a higher serum level.
Tenofovir Tenofovir Pamidronic acid may increase the nephrotoxic activities of Tenofovir.
Choline Magnesium Trisalicylate Choline Magnesium Trisalicylate The risk or severity of gastrointestinal bleeding can be increased when Choline magnesium trisalicylate is combined with Pamidronic acid.
Zonisamide Zonisamide Pamidronic acid may decrease the excretion rate of Zonisamide which could result in a higher serum level.
Atomoxetine Atomoxetine Pamidronic acid may decrease the excretion rate of Atomoxetine which could result in a higher serum level.
Atazanavir Atazanavir The risk or severity of nephrotoxicity and hypocalcemia can be increased when Atazanavir is combined with Pamidronic acid.
Almotriptan Almotriptan Pamidronic acid may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Mefloquine Mefloquine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Mefloquine.
Rosuvastatin Rosuvastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Rosuvastatin.
Emtricitabine Emtricitabine Pamidronic acid may decrease the excretion rate of Emtricitabine which could result in a higher serum level.
Memantine Memantine Pamidronic acid may decrease the excretion rate of Memantine which could result in a higher serum level.
Tadalafil Tadalafil Pamidronic acid may decrease the excretion rate of Tadalafil which could result in a higher serum level.
Darbepoetin Alfa Injection Darbepoetin Alfa Injection The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Pamidronic acid.
Infliximab Injection Infliximab Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Infliximab is combined with Pamidronic acid.
Duloxetine Duloxetine Pamidronic acid may decrease the excretion rate of Duloxetine which could result in a higher serum level.
Tinidazole Tinidazole Pamidronic acid may decrease the excretion rate of Tinidazole which could result in a higher serum level.
Cefditoren Cefditoren Pamidronic acid may decrease the excretion rate of Cefdinir which could result in a higher serum level.
Cyanocobalamin Injection Cyanocobalamin Injection Pamidronic acid may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.
Eszopiclone Eszopiclone Pamidronic acid may decrease the excretion rate of Eszopiclone which could result in a higher serum level.
Ganciclovir Ganciclovir Pamidronic acid may decrease the excretion rate of Ganciclovir which could result in a higher serum level.
Ribavirin Ribavirin Pamidronic acid may decrease the excretion rate of Ribavirin which could result in a higher serum level.
Valganciclovir Valganciclovir Pamidronic acid may decrease the excretion rate of Valganciclovir which could result in a higher serum level.
Zoledronic Acid Injection Zoledronic Acid Injection The risk or severity of nephrotoxicity and hypocalcemia can be increased when Pamidronic acid is combined with Zoledronic acid.
Adefovir Adefovir The risk or severity of nephrotoxicity and hypocalcemia can be increased when Adefovir is combined with Pamidronic acid.
Dextroamphetamine Dextroamphetamine Pamidronic acid may decrease the excretion rate of Amphetamine which could result in a higher serum level.
Ibandronate Ibandronate The risk or severity of nephrotoxicity and hypocalcemia can be increased when Pamidronic acid is combined with Ibandronate.
Ramelteon Ramelteon Pamidronic acid may decrease the excretion rate of Ramelteon which could result in a higher serum level.
Fentanyl Fentanyl Pamidronic acid may decrease the excretion rate of Fentanyl which could result in a higher serum level.
Pregabalin Pregabalin Pamidronic acid may decrease the excretion rate of Pregabalin which could result in a higher serum level.
Deferasirox Deferasirox The risk or severity of gastrointestinal bleeding and gastrointestinal ulceration can be increased when Pamidronic acid is combined with Deferasirox.
Ranolazine Ranolazine Pamidronic acid may decrease the excretion rate of Ranolazine which could result in a higher serum level.
Rasagiline Rasagiline Pamidronic acid may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Sitagliptin Sitagliptin Pamidronic acid may decrease the excretion rate of Sitagliptin which could result in a higher serum level.
Varenicline Varenicline Pamidronic acid may decrease the excretion rate of Varenicline which could result in a higher serum level.
Bevacizumab Injection Bevacizumab Injection The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when Bevacizumab is combined with Pamidronic acid.
Albuterol Albuterol Pamidronic acid may decrease the excretion rate of Salbutamol which could result in a higher serum level.
Paliperidone Paliperidone Pamidronic acid may decrease the excretion rate of Paliperidone which could result in a higher serum level.
Clofarabine Injection Clofarabine Injection Pamidronic acid may decrease the excretion rate of Clofarabine which could result in a higher serum level.
Lubiprostone Lubiprostone Pamidronic acid may decrease the excretion rate of Lubiprostone which could result in a higher serum level.
Pemetrexed Injection Pemetrexed Injection Pamidronic acid may decrease the excretion rate of Pemetrexed which could result in a higher serum level.
Ranibizumab Injection Ranibizumab Injection The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when Ranibizumab is combined with Pamidronic acid.
Sorafenib Sorafenib Pamidronic acid may decrease the excretion rate of Sorafenib which could result in a higher serum level.
Sunitinib Sunitinib The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when Sunitinib is combined with Pamidronic acid.
Levocetirizine Levocetirizine Pamidronic acid may decrease the excretion rate of Levocetirizine which could result in a higher serum level.
Pegaptanib Injection Pegaptanib Injection Pamidronic acid may decrease the excretion rate of Pegaptanib which could result in a higher serum level.
Azacitidine Injection Azacitidine Injection Pamidronic acid may decrease the excretion rate of Azacitidine which could result in a higher serum level.
Ivermectin Ivermectin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Ivermectin.
Lenalidomide Lenalidomide The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when Lenalidomide is combined with Pamidronic acid.
Raltegravir Raltegravir The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Raltegravir.
Budesonide Budesonide Pamidronic acid may decrease the excretion rate of Budesonide which could result in a higher serum level.
Desmopressin Desmopressin Pamidronic acid may decrease the excretion rate of Desmopressin which could result in a higher serum level.
Doripenem Injection Doripenem Injection Pamidronic acid may decrease the excretion rate of Doripenem which could result in a higher serum level.
Arsenic Trioxide Injection Arsenic Trioxide Injection Pamidronic acid may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.
Desvenlafaxine Desvenlafaxine Pamidronic acid may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level.
Cevimeline Cevimeline Pamidronic acid may decrease the excretion rate of Cevimeline which could result in a higher serum level.
Certolizumab Injection Certolizumab Injection Pamidronic acid may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.
Daptomycin Injection Daptomycin Injection Pamidronic acid may decrease the excretion rate of Daptomycin which could result in a higher serum level.
Methylnaltrexone Injection Methylnaltrexone Injection Pamidronic acid may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.
Midazolam Midazolam Pamidronic acid may decrease the excretion rate of Midazolam which could result in a higher serum level.
Naltrexone Injection Naltrexone Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Naltrexone.
Dexrazoxane Injection Dexrazoxane Injection Pamidronic acid may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.
Milnacipran Milnacipran Pamidronic acid may decrease the excretion rate of Milnacipran which could result in a higher serum level.
Plerixafor Injection Plerixafor Injection Pamidronic acid may decrease the excretion rate of Plerixafor which could result in a higher serum level.
Fesoterodine Fesoterodine Pamidronic acid may decrease the excretion rate of Fesoterodine which could result in a higher serum level.
Prasugrel Prasugrel Pamidronic acid may decrease the excretion rate of Prasugrel which could result in a higher serum level.
Pralatrexate Injection Pralatrexate Injection Pamidronic acid may decrease the excretion rate of Pralatrexate which could result in a higher serum level.
Palonosetron Injection Palonosetron Injection Pamidronic acid may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Saxagliptin Saxagliptin Pamidronic acid may decrease the excretion rate of Saxagliptin which could result in a higher serum level.
Telavancin Injection Telavancin Injection Pamidronic acid may decrease the excretion rate of Telavancin which could result in a higher serum level.
Topotecan Topotecan Pamidronic acid may decrease the excretion rate of Topotecan which could result in a higher serum level.
Pazopanib Pazopanib The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when Pazopanib is combined with Pamidronic acid.
Pitavastatin Pitavastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Pitavastatin.
Dalfampridine Dalfampridine Pamidronic acid may decrease the excretion rate of Dalfampridine which could result in a higher serum level.
Ceftaroline Injection Ceftaroline Injection The risk or severity of nephrotoxicity and hypocalcemia can be increased when Ceftaroline fosamil is combined with Pamidronic acid.
Acetaminophen Injection Acetaminophen Injection Pamidronic acid may decrease the excretion rate of Acetaminophen which could result in a higher serum level.
Ipilimumab Injection Ipilimumab Injection Pamidronic acid may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Denileukin Diftitox Injection Denileukin Diftitox Injection Pamidronic acid may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
Terbutaline Injection Terbutaline Injection Pamidronic acid may decrease the excretion rate of Terbutaline which could result in a higher serum level.
Roflumilast Roflumilast Pamidronic acid may decrease the excretion rate of Roflumilast which could result in a higher serum level.
Rivaroxaban Rivaroxaban Pamidronic acid may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.
Ruxolitinib Ruxolitinib Pamidronic acid may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.
Clobazam Clobazam Pamidronic acid may decrease the excretion rate of Clobazam which could result in a higher serum level.
Deferiprone Deferiprone Pamidronic acid may decrease the excretion rate of Deferiprone which could result in a higher serum level.
Naloxone Injection Naloxone Injection Pamidronic acid may decrease the excretion rate of Naloxone which could result in a higher serum level.
Fondaparinux Injection Fondaparinux Injection Pamidronic acid may decrease the excretion rate of Fondaparinux which could result in a higher serum level.
Iloprost Iloprost The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Iloprost.
Enzalutamide Enzalutamide Pamidronic acid may decrease the excretion rate of Enzalutamide which could result in a higher serum level.
Mirabegron Mirabegron Pamidronic acid may decrease the excretion rate of Mirabegron which could result in a higher serum level.
Teduglutide Injection Teduglutide Injection Pamidronic acid may decrease the excretion rate of Teduglutide which could result in a higher serum level.
Alogliptin Alogliptin Pamidronic acid may decrease the excretion rate of Alogliptin which could result in a higher serum level.
Pomalidomide Pomalidomide The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when Pomalidomide is combined with Pamidronic acid.
Canagliflozin Canagliflozin Pamidronic acid may decrease the excretion rate of Canagliflozin which could result in a higher serum level.
Trametinib Trametinib Pamidronic acid may decrease the excretion rate of Trametinib which could result in a higher serum level.
Levomilnacipran Levomilnacipran Pamidronic acid may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.
Ertapenem Injection Ertapenem Injection Pamidronic acid may decrease the excretion rate of Ertapenem which could result in a higher serum level.
Vortioxetine Vortioxetine Pamidronic acid may decrease the excretion rate of Vortioxetine which could result in a higher serum level.
Ketorolac Injection Ketorolac Injection The risk or severity of gastrointestinal bleeding can be increased when Ketorolac is combined with Pamidronic acid.
Sofosbuvir Sofosbuvir Pamidronic acid may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
Iron Sucrose Injection Iron Sucrose Injection Iron sucrose can cause a decrease in the absorption of Pamidronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Apremilast Apremilast Pamidronic acid may decrease the excretion rate of Apremilast which could result in a higher serum level.
Droxidopa Droxidopa Pamidronic acid may decrease the excretion rate of Droxidopa which could result in a higher serum level.
Testosterone Injection Testosterone Injection Pamidronic acid may decrease the excretion rate of Testosterone which could result in a higher serum level.
Edoxaban Edoxaban Pamidronic acid may decrease the excretion rate of Edoxaban which could result in a higher serum level.
Methamphetamine Methamphetamine Pamidronic acid may decrease the excretion rate of Metamfetamine which could result in a higher serum level.
Tasimelteon Tasimelteon Pamidronic acid may decrease the excretion rate of Tasimelteon which could result in a higher serum level.
Haloperidol Injection Haloperidol Injection Pamidronic acid may decrease the excretion rate of Haloperidol which could result in a higher serum level.
Macitentan Macitentan Pamidronic acid may decrease the excretion rate of Macitentan which could result in a higher serum level.
Penicillin G Procaine Injection Penicillin G Procaine Injection Pamidronic acid may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.
Trabectedin Injection Trabectedin Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Trabectedin.
Ixazomib Ixazomib Pamidronic acid may decrease the excretion rate of Ixazomib which could result in a higher serum level.
Lesinurad Lesinurad Pamidronic acid may decrease the excretion rate of Lesinurad which could result in a higher serum level.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection The risk or severity of nephrotoxicity and hypocalcemia can be increased when Amphotericin B is combined with Pamidronic acid.
Dexamethasone Injection Dexamethasone Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Dexamethasone.
Brivaracetam Injection Brivaracetam Injection Pamidronic acid may decrease the excretion rate of Brivaracetam which could result in a higher serum level.
Furosemide Injection Furosemide Injection The risk or severity of hypocalcemia can be increased when Furosemide is combined with Pamidronic acid.
Lixisenatide Injection Lixisenatide Injection Pamidronic acid may decrease the excretion rate of Lixisenatide which could result in a higher serum level.
Parathyroid Hormone Injection Parathyroid Hormone Injection The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Pamidronic acid.
Doxepin (Insomnia) Doxepin (Insomnia) Pamidronic acid may decrease the excretion rate of Doxepin which could result in a higher serum level.
Deutetrabenazine Deutetrabenazine Pamidronic acid may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.
Valbenazine Valbenazine Pamidronic acid may decrease the excretion rate of Valbenazine which could result in a higher serum level.
Naldemedine Naldemedine Pamidronic acid may decrease the excretion rate of Naldemedine which could result in a higher serum level.
Benznidazole Benznidazole Pamidronic acid may decrease the excretion rate of Benznidazole which could result in a higher serum level.
Delafloxacin Delafloxacin Pamidronic acid may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Apalutamide Apalutamide Pamidronic acid may decrease the excretion rate of Apalutamide which could result in a higher serum level.
Penicillamine Penicillamine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Penicillamine.
Baricitinib Baricitinib Pamidronic acid may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Lofexidine Lofexidine Pamidronic acid may decrease the excretion rate of Lofexidine which could result in a higher serum level.
Plazomicin Injection Plazomicin Injection Pamidronic acid may decrease the excretion rate of Plazomicin which could result in a higher serum level.
Stiripentol Stiripentol Pamidronic acid may decrease the excretion rate of Stiripentol which could result in a higher serum level.
Methoxy Polyethylene Glycol-Epoetin Beta Injection Methoxy Polyethylene Glycol-Epoetin Beta Injection The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Pamidronic acid.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Paclitaxel.
Prucalopride Prucalopride Pamidronic acid may decrease the excretion rate of Prucalopride which could result in a higher serum level.
Acyclovir Ophthalmic Acyclovir Ophthalmic The risk or severity of nephrotoxicity and hypocalcemia can be increased when Acyclovir is combined with Pamidronic acid.
Cladribine Cladribine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cladribine is combined with Pamidronic acid.
Solriamfetol Solriamfetol Pamidronic acid may decrease the excretion rate of Solriamfetol which could result in a higher serum level.
Pitolisant Pitolisant Pamidronic acid may decrease the excretion rate of Pitolisant which could result in a higher serum level.
Phenytoin Injection Phenytoin Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Phenytoin is combined with Pamidronic acid.
Brolucizumab-dbll Injection Brolucizumab-dbll Injection The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when Brolucizumab is combined with Pamidronic acid.
Calcium Acetate Calcium Acetate The serum concentration of Pamidronic acid can be decreased when it is combined with Calcium acetate.
Viloxazine Viloxazine Pamidronic acid may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Tobramycin Injection Tobramycin Injection Tobramycin may decrease the excretion rate of Pamidronic acid which could result in a higher serum level.
Fenoprofen Fenoprofen The risk or severity of gastrointestinal bleeding can be increased when Fenoprofen is combined with Pamidronic acid.
Indomethacin Indomethacin The risk or severity of gastrointestinal bleeding can be increased when Indomethacin is combined with Pamidronic acid.
Mefenamic Acid Mefenamic Acid The risk or severity of gastrointestinal bleeding can be increased when Mefenamic acid is combined with Pamidronic acid.
Naproxen Naproxen The risk or severity of gastrointestinal bleeding can be increased when Naproxen is combined with Pamidronic acid.
Tolmetin Tolmetin The risk or severity of gastrointestinal bleeding can be increased when Tolmetin is combined with Pamidronic acid.
Sulindac Sulindac The risk or severity of gastrointestinal bleeding can be increased when Sulindac is combined with Pamidronic acid.
Isotretinoin Isotretinoin Pamidronic acid may decrease the excretion rate of Isotretinoin which could result in a higher serum level.
Sucralfate Sucralfate Pamidronic acid may decrease the excretion rate of Sucralfate which could result in a higher serum level.
Sodium Bicarbonate Sodium Bicarbonate The serum concentration of Pamidronic acid can be decreased when it is combined with Sodium bicarbonate.
Floxuridine Floxuridine Pamidronic acid may decrease the excretion rate of Floxuridine which could result in a higher serum level.
Metaxalone Metaxalone Pamidronic acid may decrease the excretion rate of Metaxalone which could result in a higher serum level.
Methotrexate Injection Methotrexate Injection The risk or severity of nephrotoxicity and hypocalcemia can be increased when Methotrexate is combined with Pamidronic acid.
Chlorpromazine Chlorpromazine Pamidronic acid may decrease the excretion rate of Chlorpromazine which could result in a higher serum level.
Diazepam Diazepam Pamidronic acid may decrease the excretion rate of Diazepam which could result in a higher serum level.
Oxazepam Oxazepam Pamidronic acid may decrease the excretion rate of Oxazepam which could result in a higher serum level.
Flurazepam Flurazepam Pamidronic acid may decrease the excretion rate of Flurazepam which could result in a higher serum level.
Clorazepate Clorazepate Pamidronic acid may decrease the excretion rate of Clorazepic acid which could result in a higher serum level.
Lorazepam Lorazepam Pamidronic acid may decrease the excretion rate of Lorazepam which could result in a higher serum level.
Carmustine Carmustine Pamidronic acid may decrease the excretion rate of Carmustine which could result in a higher serum level.
Amantadine Amantadine Pamidronic acid may decrease the excretion rate of Amantadine which could result in a higher serum level.
Codeine Codeine Pamidronic acid may decrease the excretion rate of Codeine which could result in a higher serum level.
Phenelzine Phenelzine Pamidronic acid may decrease the excretion rate of Phenelzine which could result in a higher serum level.
Procarbazine Procarbazine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Procarbazine.
Tetracycline Tetracycline Pamidronic acid may decrease the excretion rate of Tetracycline which could result in a higher serum level.
Minocycline Minocycline The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Minocycline.
Bleomycin Bleomycin Pamidronic acid may decrease the excretion rate of Bleomycin which could result in a higher serum level.
Sulfadiazine Sulfadiazine Pamidronic acid may decrease the excretion rate of Sulfadiazine which could result in a higher serum level.
Methadone Methadone Pamidronic acid may decrease the excretion rate of Methadone which could result in a higher serum level.
Benztropine Benztropine Pamidronic acid may decrease the excretion rate of Benzatropine which could result in a higher serum level.
Maprotiline Maprotiline Pamidronic acid may decrease the excretion rate of Maprotiline which could result in a higher serum level.
Ibuprofen Ibuprofen The risk or severity of gastrointestinal bleeding can be increased when Ibuprofen is combined with Pamidronic acid.
Azathioprine Azathioprine Pamidronic acid may decrease the excretion rate of Azathioprine which could result in a higher serum level.
Methylphenidate Methylphenidate Pamidronic acid may decrease the excretion rate of Methylphenidate which could result in a higher serum level.
Sulfasalazine Sulfasalazine The risk or severity of gastrointestinal bleeding can be increased when Sulfasalazine is combined with Pamidronic acid.
Cytarabine Cytarabine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Cytarabine.
Phenazopyridine Phenazopyridine The risk or severity of nephrotoxicity can be increased when Pamidronic acid is combined with Phenazopyridine.
Carbamazepine Carbamazepine Pamidronic acid may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Methyldopa Methyldopa Pamidronic acid may decrease the excretion rate of Methyldopa which could result in a higher serum level.
Hydralazine Hydralazine Pamidronic acid may decrease the excretion rate of Hydralazine which could result in a higher serum level.
Cimetidine Cimetidine Pamidronic acid may decrease the excretion rate of Cimetidine which could result in a higher serum level.
Gentamicin Injection Gentamicin Injection Gentamicin may decrease the excretion rate of Pamidronic acid which could result in a higher serum level.
Warfarin Warfarin Pamidronic acid may decrease the excretion rate of Warfarin which could result in a higher serum level.
Clonazepam Clonazepam Pamidronic acid may decrease the excretion rate of Clonazepam which could result in a higher serum level.
Promethazine Promethazine Pamidronic acid may decrease the excretion rate of Promethazine which could result in a higher serum level.
Meclofenamate Meclofenamate The risk or severity of gastrointestinal bleeding can be increased when Meclofenamic acid is combined with Pamidronic acid.
Nitrofurantoin Nitrofurantoin Pamidronic acid may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.
Digoxin Digoxin Pamidronic acid may decrease the excretion rate of Digoxin which could result in a higher serum level.
Chloroquine Chloroquine Pamidronic acid may decrease the excretion rate of Chloroquine which could result in a higher serum level.
Triamterene Triamterene The risk or severity of nephrotoxicity can be increased when Pamidronic acid is combined with Triamterene.
Metolazone Metolazone Pamidronic acid may decrease the excretion rate of Metolazone which could result in a higher serum level.
Secobarbital Secobarbital Pamidronic acid may decrease the excretion rate of Secobarbital which could result in a higher serum level.
Desipramine Desipramine Pamidronic acid may decrease the excretion rate of Desipramine which could result in a higher serum level.
Amitriptyline Amitriptyline Pamidronic acid may decrease the excretion rate of Amitriptyline which could result in a higher serum level.
Imipramine Imipramine Pamidronic acid may decrease the excretion rate of Imipramine which could result in a higher serum level.
Probenecid Probenecid Pamidronic acid may decrease the excretion rate of Probenecid which could result in a higher serum level.
Quinidine Quinidine Pamidronic acid may decrease the excretion rate of Quinidine which could result in a higher serum level.
Procainamide Procainamide Pamidronic acid may decrease the excretion rate of Procainamide which could result in a higher serum level.
Isoniazid Isoniazid Pamidronic acid may decrease the excretion rate of Isoniazid which could result in a higher serum level.
Pyrazinamide Pyrazinamide Pamidronic acid may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.
Disopyramide Disopyramide Pamidronic acid may decrease the excretion rate of Disopyramide which could result in a higher serum level.
Butabarbital Butabarbital Pamidronic acid may decrease the excretion rate of Butabarbital which could result in a higher serum level.
Liothyronine Liothyronine Pamidronic acid may decrease the excretion rate of Liothyronine which could result in a higher serum level.
Methimazole Methimazole Pamidronic acid may decrease the excretion rate of Methimazole which could result in a higher serum level.
Propylthiouracil Propylthiouracil The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Propylthiouracil.
Chlorpropamide Chlorpropamide Pamidronic acid may decrease the excretion rate of Chlorpropamide which could result in a higher serum level.
Tolbutamide Tolbutamide Pamidronic acid may decrease the excretion rate of Tolbutamide which could result in a higher serum level.
Tolazamide Tolazamide Pamidronic acid may decrease the excretion rate of Tolazamide which could result in a higher serum level.
Niacin Niacin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Niacin.
Baclofen Baclofen Pamidronic acid may decrease the excretion rate of Baclofen which could result in a higher serum level.
Ethambutol Ethambutol Pamidronic acid may decrease the excretion rate of Ethambutol which could result in a higher serum level.
Hydrochlorothiazide Hydrochlorothiazide The risk or severity of nephrotoxicity can be increased when Pamidronic acid is combined with Hydrochlorothiazide.
Chlorzoxazone Chlorzoxazone Pamidronic acid may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level.
Pyridoxine Pyridoxine Pamidronic acid may decrease the excretion rate of Pyridoxine which could result in a higher serum level.
Folic Acid Folic Acid Pamidronic acid may decrease the excretion rate of Folic acid which could result in a higher serum level.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) Pamidronic acid may decrease the excretion rate of Propranolol which could result in a higher serum level.
Amphotericin B Injection Amphotericin B Injection The risk or severity of nephrotoxicity and hypocalcemia can be increased when Amphotericin B is combined with Pamidronic acid.
Phytonadione Phytonadione Pamidronic acid may decrease the excretion rate of Phylloquinone which could result in a higher serum level.
Amikacin Injection Amikacin Injection Amikacin may decrease the excretion rate of Pamidronic acid which could result in a higher serum level.
Nadolol Nadolol Pamidronic acid may decrease the excretion rate of Nadolol which could result in a higher serum level.
Allopurinol Allopurinol Pamidronic acid may decrease the excretion rate of Allopurinol which could result in a higher serum level.
Flavoxate Flavoxate Pamidronic acid may decrease the excretion rate of Flavoxate which could result in a higher serum level.
Colchicine Colchicine Pamidronic acid may decrease the excretion rate of Colchicine which could result in a higher serum level.
Cefaclor Cefaclor The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefaclor is combined with Pamidronic acid.
Cefadroxil Cefadroxil The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefadroxil is combined with Pamidronic acid.
Cefazolin Injection Cefazolin Injection The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefazolin is combined with Pamidronic acid.
Cephalexin Cephalexin The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cephalexin is combined with Pamidronic acid.
Cefoxitin Injection Cefoxitin Injection The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefoxitin is combined with Pamidronic acid.
Dacarbazine Dacarbazine Pamidronic acid may decrease the excretion rate of Dacarbazine which could result in a higher serum level.
Cefotaxime Injection Cefotaxime Injection The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefotaxime is combined with Pamidronic acid.
Calcitonin Salmon Injection Calcitonin Salmon Injection The risk or severity of hypocalcemia can be increased when Pamidronic acid is combined with Salmon calcitonin.
Pyrantel Pyrantel Pamidronic acid may decrease the excretion rate of Pyrantel which could result in a higher serum level.
Vincristine Injection Vincristine Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Vincristine.
Captopril Captopril The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Captopril.
Ethacrynic Acid Ethacrynic Acid The risk or severity of hypocalcemia can be increased when Etacrynic acid is combined with Pamidronic acid.
Colistimethate Injection Colistimethate Injection The risk or severity of nephrotoxicity and hypocalcemia can be increased when Colistimethate is combined with Pamidronic acid.
Metoprolol Metoprolol Pamidronic acid may decrease the excretion rate of Metoprolol which could result in a higher serum level.
Aspirin Aspirin The risk or severity of gastrointestinal bleeding can be increased when Acetylsalicylic acid is combined with Pamidronic acid.
Salsalate Salsalate The risk or severity of gastrointestinal bleeding can be increased when Salsalate is combined with Pamidronic acid.
Alprazolam Alprazolam Pamidronic acid may decrease the excretion rate of Alprazolam which could result in a higher serum level.
Temazepam Temazepam Pamidronic acid may decrease the excretion rate of Temazepam which could result in a higher serum level.
Triazolam Triazolam Pamidronic acid may decrease the excretion rate of Triazolam which could result in a higher serum level.
Dicyclomine Dicyclomine Pamidronic acid may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Propantheline Propantheline Pamidronic acid may decrease the excretion rate of Propantheline which could result in a higher serum level.
Trimethoprim Trimethoprim Pamidronic acid may decrease the excretion rate of Trimethoprim which could result in a higher serum level.
Nifedipine Nifedipine Pamidronic acid may decrease the excretion rate of Nifedipine which could result in a higher serum level.
Timolol Timolol Pamidronic acid may decrease the excretion rate of Timolol which could result in a higher serum level.
Verapamil Verapamil Pamidronic acid may decrease the excretion rate of Verapamil which could result in a higher serum level.
Pindolol Pindolol Pamidronic acid may decrease the excretion rate of Pindolol which could result in a higher serum level.
Cisplatin Injection Cisplatin Injection Pamidronic acid may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Diflunisal Diflunisal The risk or severity of gastrointestinal bleeding can be increased when Diflunisal is combined with Pamidronic acid.
Piroxicam Piroxicam The risk or severity of gastrointestinal bleeding can be increased when Piroxicam is combined with Pamidronic acid.
Bumetanide Bumetanide The risk or severity of hypocalcemia can be increased when Bumetanide is combined with Pamidronic acid.
Glipizide Glipizide Pamidronic acid may decrease the excretion rate of Glipizide which could result in a higher serum level.
Indapamide Indapamide Pamidronic acid may decrease the excretion rate of Indapamide which could result in a higher serum level.
Amoxicillin Amoxicillin Pamidronic acid may decrease the excretion rate of Amoxicillin which could result in a higher serum level.
Oxacillin Injection Oxacillin Injection Pamidronic acid may decrease the excretion rate of Oxacillin which could result in a higher serum level.
Pentoxifylline Pentoxifylline Pamidronic acid may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.
Pentamidine Injection Pentamidine Injection The risk or severity of nephrotoxicity and hypocalcemia can be increased when Pentamidine is combined with Pamidronic acid.
Ceftriaxone Injection Ceftriaxone Injection The risk or severity of nephrotoxicity and hypocalcemia can be increased when Ceftriaxone is combined with Pamidronic acid.
Labetalol Labetalol Pamidronic acid may decrease the excretion rate of Labetalol which could result in a higher serum level.
Auranofin Auranofin Pamidronic acid may decrease the excretion rate of Auranofin which could result in a higher serum level.
Leuprolide Injection Leuprolide Injection Pamidronic acid may decrease the excretion rate of Leuprolide which could result in a higher serum level.
Gemfibrozil Gemfibrozil Pamidronic acid may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.
Dipivefrin Ophthalmic Dipivefrin Ophthalmic The risk or severity of nephrotoxicity and hypocalcemia can be increased when Adefovir dipivoxil is combined with Pamidronic acid.
Ceftazidime Injection Ceftazidime Injection The risk or severity of nephrotoxicity and hypocalcemia can be increased when Ceftazidime is combined with Pamidronic acid.
Ketoprofen Ketoprofen The risk or severity of gastrointestinal bleeding can be increased when Ketoprofen is combined with Pamidronic acid.
Cefotetan Injection Cefotetan Injection The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefotetan is combined with Pamidronic acid.
Enalapril Enalapril The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Enalapril.
Flurbiprofen Flurbiprofen The risk or severity of gastrointestinal bleeding can be increased when Flurbiprofen is combined with Pamidronic acid.
Amiodarone Amiodarone The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Amiodarone.
Aztreonam Injection Aztreonam Injection Pamidronic acid may decrease the excretion rate of Aztreonam which could result in a higher serum level.
Buspirone Buspirone Pamidronic acid may decrease the excretion rate of Buspirone which could result in a higher serum level.
Lovastatin Lovastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lovastatin is combined with Pamidronic acid.
Ciprofloxacin Ciprofloxacin Pamidronic acid may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Mesalamine Mesalamine The risk or severity of gastrointestinal bleeding can be increased when Mesalazine is combined with Pamidronic acid.
Diclofenac Diclofenac The risk or severity of gastrointestinal bleeding can be increased when Diclofenac is combined with Pamidronic acid.
Clozapine Clozapine Pamidronic acid may decrease the excretion rate of Clozapine which could result in a higher serum level.
Estazolam Estazolam Pamidronic acid may decrease the excretion rate of Estazolam which could result in a higher serum level.
Ofloxacin Ofloxacin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Ofloxacin.
Didanosine Didanosine Pamidronic acid may decrease the excretion rate of Didanosine which could result in a higher serum level.
Pentostatin Injection Pentostatin Injection Pamidronic acid may decrease the excretion rate of Pentostatin which could result in a higher serum level.
Etodolac Etodolac The risk or severity of gastrointestinal bleeding can be increased when Etodolac is combined with Pamidronic acid.
Fosinopril Fosinopril Pamidronic acid may decrease the excretion rate of Fosinopril which could result in a higher serum level.
Nabumetone Nabumetone The risk or severity of gastrointestinal bleeding can be increased when Nabumetone is combined with Pamidronic acid.
Pravastatin Pravastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Pamidronic acid.
Simvastatin Simvastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Simvastatin.
Epoetin Alfa, Injection Epoetin Alfa, Injection The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pamidronic acid.
Lisinopril Lisinopril Pamidronic acid may decrease the excretion rate of Lisinopril which could result in a higher serum level.
Oxaprozin Oxaprozin The risk or severity of gastrointestinal bleeding can be increased when Oxaprozin is combined with Pamidronic acid.
Bisoprolol Bisoprolol Pamidronic acid may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Isradipine Isradipine Pamidronic acid may decrease the excretion rate of Isradipine which could result in a higher serum level.
Fluvastatin Fluvastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Fluvastatin.
Venlafaxine Venlafaxine Pamidronic acid may decrease the excretion rate of Venlafaxine which could result in a higher serum level.
Nizatidine Nizatidine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Nizatidine.
Stavudine Stavudine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Stavudine.
Fluvoxamine Fluvoxamine Pamidronic acid may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Nefazodone Nefazodone Pamidronic acid may decrease the excretion rate of Nefazodone which could result in a higher serum level.
Lamotrigine Lamotrigine Pamidronic acid may decrease the excretion rate of Lamotrigine which could result in a higher serum level.
Valacyclovir Valacyclovir The risk or severity of nephrotoxicity and hypocalcemia can be increased when Valaciclovir is combined with Pamidronic acid.
Tramadol Tramadol Pamidronic acid may decrease the excretion rate of Tramadol which could result in a higher serum level.
Carboplatin Injection Carboplatin Injection The risk or severity of nephrotoxicity and hypocalcemia can be increased when Carboplatin is combined with Pamidronic acid.
Ifosfamide Injection Ifosfamide Injection Pamidronic acid may decrease the excretion rate of Ifosfamide which could result in a higher serum level.
Bupropion Bupropion Pamidronic acid may decrease the excretion rate of Bupropion which could result in a higher serum level.
Ticlopidine Ticlopidine Pamidronic acid may decrease the excretion rate of Ticlopidine which could result in a higher serum level.
Saquinavir Saquinavir The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Saquinavir.
Metformin Metformin Pamidronic acid may decrease the excretion rate of Metformin which could result in a higher serum level.
Nisoldipine Nisoldipine Pamidronic acid may decrease the excretion rate of Nisoldipine which could result in a higher serum level.
Lamivudine Lamivudine Pamidronic acid may decrease the excretion rate of Lamivudine which could result in a higher serum level.
Acarbose Acarbose Pamidronic acid may decrease the excretion rate of Acarbose which could result in a higher serum level.
Gemcitabine Injection Gemcitabine Injection Pamidronic acid may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Indinavir Indinavir The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Pamidronic acid.
Ritonavir Ritonavir The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Ritonavir.
Docetaxel Injection Docetaxel Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Docetaxel.
Cidofovir Injection Cidofovir Injection The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cidofovir is combined with Pamidronic acid.
Meropenem Injection Meropenem Injection Pamidronic acid may decrease the excretion rate of Meropenem which could result in a higher serum level.
Clomipramine Clomipramine Pamidronic acid may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Fosfomycin Fosfomycin Pamidronic acid may decrease the excretion rate of Fosfomycin which could result in a higher serum level.
Topiramate Topiramate Pamidronic acid may decrease the excretion rate of Topiramate which could result in a higher serum level.
Pramipexole Pramipexole Pamidronic acid may decrease the excretion rate of Pramipexole which could result in a higher serum level.
Nilutamide Nilutamide Pamidronic acid may decrease the excretion rate of Nilutamide which could result in a higher serum level.
Flutamide Flutamide Pamidronic acid may decrease the excretion rate of Flutamide which could result in a higher serum level.
Letrozole Letrozole The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Letrozole.
Tamsulosin Tamsulosin Pamidronic acid may decrease the excretion rate of Tamsulosin which could result in a higher serum level.
Quetiapine Quetiapine Pamidronic acid may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Cefepime Injection Cefepime Injection The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefepime is combined with Pamidronic acid.
Cefprozil Cefprozil The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefprozil is combined with Pamidronic acid.
Cefpodoxime Cefpodoxime The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefpodoxime is combined with Pamidronic acid.
Cetirizine Cetirizine Pamidronic acid may decrease the excretion rate of Cetirizine which could result in a higher serum level.
Tolcapone Tolcapone Pamidronic acid may decrease the excretion rate of Tolcapone which could result in a higher serum level.
Capecitabine Capecitabine Pamidronic acid may decrease the excretion rate of Capecitabine which could result in a higher serum level.
Abacavir Abacavir Pamidronic acid may decrease the excretion rate of Abacavir which could result in a higher serum level.
Sildenafil Sildenafil The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Sildenafil is combined with Pamidronic acid.
Celecoxib Celecoxib The risk or severity of gastrointestinal bleeding can be increased when Celecoxib is combined with Pamidronic acid.
Rosiglitazone Rosiglitazone Pamidronic acid may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.
Tolterodine Tolterodine Pamidronic acid may decrease the excretion rate of Tolterodine which could result in a higher serum level.
Thalidomide Thalidomide The risk or severity of nephrotoxicity can be increased when Thalidomide is combined with Pamidronic acid.
Oseltamivir Oseltamivir Pamidronic acid may decrease the excretion rate of Oseltamivir which could result in a higher serum level.
Aluminum Hydroxide Aluminum Hydroxide The serum concentration of Pamidronic acid can be decreased when it is combined with Aluminum hydroxide.
Balsalazide Balsalazide The risk or severity of gastrointestinal bleeding can be increased when Balsalazide is combined with Pamidronic acid.
Nateglinide Nateglinide Pamidronic acid may decrease the excretion rate of Nateglinide which could result in a higher serum level.
Rabeprazole Rabeprazole Pamidronic acid may decrease the excretion rate of Rabeprazole which could result in a higher serum level.
Terbinafine Terbinafine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Terbinafine.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists